PD-L1 is commonly overexpressed on tumour cells in the TME and its ligation with PD-1 receptors on activated T cells leads to the inhibition of effector CTL responses [51], thus contributing to immune escape mechanisms associated with poor survival outcomes [53,70,71]. This evidence concerns the gene CD274 and neoplasm.